类风湿关节炎抑郁和焦虑筛查量表的效度与信度
该研究在150例类风湿关节炎(RA)患者中,以SCID-1诊断为金标准,评估多种抑郁和焦虑筛查工具的效度与信度。抑郁筛查工具诊断性能良好,焦虑工具表现不一;重测信度良好(ICC 0.69–0.88)。筛查阳性者需临床确认。
要点
- 抑郁筛查工具敏感性和特异性良好,阴性预测值高。
- 焦虑筛查工具诊断性能差异较大,需谨慎解读。
- 所有筛查阳性结果均需临床确认,不能直接诊断。
核心结论
- 抑郁筛查工具在RA患者中诊断性能良好,焦虑筛查工具表现不一。
- 筛查发现的抑郁和焦虑需要临床确认。
研究设计与样本
- 纳入150例RA患者,完成多种抑郁和焦虑筛查量表。
- 以SCID-1研究版诊断作为金标准,计算敏感度、特异度、预测值及重测信度。
主要发现
- 11.3%患者有SCID-1诊断的抑郁,7.3%有广泛性焦虑障碍,19.3%有任何焦虑障碍。
- 抑郁筛查敏感度从HADS-D(切点11)的35%到PHQ-2的88%和PHQ-9的87%。
- 抑郁筛查特异度从PHQ-9的77%和PHQ-2的84%到HADS-D(切点11)的94%。
- 抑郁筛查阳性预测值30%–43%,阴性预测值92%–98%。
- 广泛性焦虑障碍筛查敏感度从HADS-A(切点11)的45%到HADS-A(切点8)的91%;除HADS-A(切点8)特异度63%外,其余工具特异度81%–89%。
关键数值与推荐
- 抑郁:HADS-D切点11敏感度35%、特异度94%;PHQ-2敏感度88%、特异度84%;PHQ-9敏感度87%、特异度77%。
- 广泛性焦虑障碍:HADS-A切点11敏感度45%;HADS-A切点8敏感度91%、特异度63%。
- 重测信度ICC范围0.69–0.88。
临床怎么用
- RA患者可使用抑郁筛查工具如PHQ-2或PHQ-9进行初筛,阳性者需临床确认。
- 焦虑筛查工具性能不一,解读结果时应结合临床评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the validity and reliability of screening instruments for depression and anxiety in rheumatoid arthritis (RA). METHODS: Participants with RA completed the Patient Health Questionnaire (PHQ-2 or PHQ-9), the Patient Reported Outcomes Measurement Information System depression short form 8a and anxiety short form 8a, the Hospital Anxiety and Depression Scale anxiety score (HADS-A) and depression score (HADS-D), the Overall Anxiety Severity and Impairment Scale, the Generalized Anxiety Disorder 2- and 7-item scales, and the Kessler-6 scale. Clinical depression and anxiety disorders were confirmed using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Axis I Disorders (SCID-1) research version. We reported sensitivity, specificity, positive predictive value, and negative predictive value using SCID-1 diagnoses as the criterion standard. Test-retest reliability was assessed with the intraclass correlation coefficient. RESULTS: Of 150 participants, 11.3% had SCID-1-diagnosed depression, 7.3% had SCID-1-diagnosed generalized anxiety disorder, and 19.3% had any SCID-1-diagnosed anxiety disorder. For depression, sensitivity ranged from HADS-D (cut point 11; 35%) to PHQ-2 (88%) and PHQ-9 (87%). Specificity ranged from PHQ-9 (77%) and PHQ-2 (84%) to HADS-D (cut point 11; 94%). Positive predictive value ranged from 30% to 43%. Negative predictive value ranged from 92% to 98%. For generalized anxiety disorder, sensitivity ranged from HADS-A (cut point 11; 45%) to HADS-A (cut point 8; 91%). Specificity ranged from 81% to 89% for all measures except the HADS-A (cut point 8; 63%). Intraclass correlation coefficient estimates ranging from 0.69 to 0.88 confirmed good test-retest reliability. CONCLUSION: Depression screening instruments had good diagnostic performance; anxiety instruments were more variable. Identified depression and anxiety require clinical confirmation.
引用
- Hitchon CA, Zhang L, Peschken CA, et al. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2020. PMID: 31199570. doi:10.1002/acr.24011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。